MiLaboratories

Overview

San Francisco-based and with an R&D facility in Bilbao, Spain, this organization specializes in computational biology. It develops advanced software platforms and tools that accelerate genomic research, focusing on the analysis of complex next-generation sequencing (NGS) data. Their flagship product, Platforma.bio Software Development Kit (SDK), enables biologists and bioinformaticians to efficiently analyze large genomic datasets, providing valuable insights for medicine, especially in immunology.

The company's software is offered free to academic users, while a subscription model serves major pharmaceutical and biotechnology firms, including Moderna and Bristol Myers Squibb. Technology features include unique molecular barcoding and advanced algorithms for profiling T-cell and B-cell repertoires, pivotal in vaccine and cancer therapy development. With robust funding, including a $10 million Series A round, the organization is expanding its U.S. footprint, strengthening its leadership in computational biology and drug discovery.

Basic Information

Contact Details

• Phone: +1 408-219-8157
• Website: milaboratories.com
• LinkedIn: linkedin.com/company/milaboratories

Key Focus Areas & Initiatives

• Computational biology for genomic research
• Software platforms for next-generation sequencing (NGS) data analysis
• Development of bioinformatics tools for immunology and drug discovery
• Unique molecular barcoding and profiling of T-cell and B-cell repertoires
• Supporting academic research through free software access
• Commercial partnerships with pharmaceutical and biotech companies
• Expansion and talent acquisition within the U.S. market

Technologies Used

• AI
• Amazon AWS
• Android
• Circle
• DNSimple
• Data Analytics
• Docker
• GitHub Hosting
• Gmail
• Google Apps
• MailJet
• Microsoft Office 365
• Mobile Friendly
• Outlook
• Proofpoint
• Remote
• Route 53

Affiliated Organizations & Regional Branches